Screening of the Oncomine database revealed that HSPA6 is overexpressed in kidney cancer, brain and CNS cancers, leukemia and lymphoma, breast cancer, cervical cancer, colorectal cancer and GC (Figure 1A). This evidence concerns the gene HSPA6 and central nervous system cancer.